Identification of microR-106b as a prognostic biomarker of p53-like bladder cancers by ActMiR

Bladder cancers can be categorized into subtypes according to gene expression patterns. P53-like muscle-invasive bladder cancers are generally resistant to cisplatin-based chemotherapy, but exhibit heterogeneous clinical outcomes with a prognosis intermediate to that of the luminal and basal subtype...

Full description

Saved in:
Bibliographic Details
Published in:Oncogene
Main Authors: Lee, Eunjee, Collazo-Lorduy, Ana, Castillo-Martin, Mireia, Gong, Yixuan, Wang, Li, Oh, William K., Galsky, Matthew D., Cordon-Cardo, Carlos, Zhu, Jun
Format: Artigo
Language:Inglês
Published: Nature Publishing Group UK 2018
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6212417/
https://ncbi.nlm.nih.gov/pubmed/29970902
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41388-018-0367-0
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items